DIN 02513161 — MAGNESIUM SULFATE INJECTION, BP 49.3% 493 MG
MAGNESIUM SULFATE INJECTION, BP 49.3% is a solution of Magnesium sulfate (oral) marketed by BAXTER CORPORATION. The full Magnesium sulfate (oral) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02513161
- Brand name
- MAGNESIUM SULFATE INJECTION, BP 49.3%
- Active ingredient
- Magnesium sulfate (oral)
- Strength
- 493 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BAXTER CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Osmotic (saline) laxative
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Magnesium sulfate (oral) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02542153 | MAGNESIUM SULFATE IN WATER FOR INJECTION | 40 MG | SOLUTION | BAXTER CORPORATION | MARKETED |
| 00504513 | MAGNESIUM SULFATE INJ 50% | 500 MG | LIQUID | KRIPPS PHARMACY LTD. | DORMANT |
| 00392618 | MAGNESIUM SULFATE INJECTION USP | 200 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02562235 | MAGNESIUM SULFATE INJECTION USP | 500 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02139499 | MAGNESIUM SULFATE INJECTION, USP | 500 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |